← Back to Clinical Trials
Recruiting NCT03829631

NCT03829631 Lumbar Brace Deployment in the Emergency Department for Benign Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03829631
Status Recruiting
Phase
Sponsor University of Alberta
Condition Low Back Pain
Study Type INTERVENTIONAL
Enrollment 152 participants
Start Date 2019-06-12
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 152 participants in total. It began in 2019-06-12 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Low back pain accounts for billions of dollars in health care expenditures. Most cases of back pain do not have a clear cause. Thus, low back pain management methods usually rely on targeting people' pain and discomfort. Painkillers, including opioids, are usually prescribed in the emergency departments for people with low back pain. But, like all medications, painkillers can have side effects, and some of those can be serious. There are also serious concerns about the overuse of painkillers. Thus, newer pain management methods are needed to reduce the use of painkillers in people with low back pain. Lumbar braces are one of the underutilized low back pain management methods in the emergency departments. Like crutches for leg and ankle injuries, they can minimise movements of the spine. This may decrease people pain and improve their function. This may also reduce the use of painkillers. In support of this approach, two recent studies conducted in a primary-care setting observed a reduction in the use of painkillers in people with low back pain who wore lumbar braces. The investigators are conducting this study to determine if wearing a lumbar brace for 4 weeks following emergency department presentation will reduce people's pain and discomfort and increase spine function. This may decrease the use of painkiller and future use of healthcare resources. This research study may also assist emergency-department staff with offering new recommendations to improve the quality of clinical decisions.

Eligibility Criteria

Inclusion Criteria: * Aged between 18 and 65 years * Ambulatory * Able to read and understand English * Living in Edmonton * Presenting to an emergency department Exclusion Criteria: * Back pain due to systemic or specific disease such as known cancer, spinal infection, fracture, or ankylosing spondylitis * Pregnancy * Significant compression of the spinal cord/nerves * Previous back surgery * On-going workers' compensation or litigation cases

Contact & Investigator

Central Contact

Vahid Abdollah, PhD

✉ v.abdollah@ualberta.ca

📞 7804928889

Principal Investigator

Vahid Abdollah, PhD

PRINCIPAL INVESTIGATOR

University of Alberta

Frequently Asked Questions

Who can join the NCT03829631 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03829631 currently recruiting?

Yes, NCT03829631 is actively recruiting participants. Contact the research team at v.abdollah@ualberta.ca for enrollment information.

Where is the NCT03829631 trial being conducted?

This trial is being conducted at Perth, Australia.

Who is sponsoring the NCT03829631 clinical trial?

NCT03829631 is sponsored by University of Alberta. The principal investigator is Vahid Abdollah, PhD at University of Alberta. The trial plans to enroll 152 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology